| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |